Omeros Corp
OMER- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001285819
In the last 90 days, Omeros Corp insiders filed 0 open-market purchases and 6 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $343.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Omeros Corp as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +8 vs. Q2 2024
- Shares held
- 25.0M
- +4.34M (+20.9%) vs. Q2 2024
- Total value
- $99.3M
- +$15.3M (+18.2%) vs. Q2 2024
- New holders
- 16
- 27 more added
- Sold out
- 8
- 34 more reduced
4 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OMER on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 171 | $343.0M |
| Q1 2026 | 162 | $326.2M |
| Q4 2025 | 151 | $570.3M |
| Q3 2025 | 133 | $134.7M |
| Q2 2025 | 128 | $87.3M |
| Q1 2025 | 137 | $226.7M |
| Q4 2024 | 128 | $262.3M |
| Q3 2024 | 108 | $99.3M |
| Q2 2024 | 104 | $101.4M |
| Q1 2024 | 99 | $87.8M |
| Q4 2023 | 97 | $81.7M |
| Q3 2023 | 100 | $78.9M |
| Q2 2023 | 103 | $142.8M |
| Q1 2023 | 91 | $94.9M |
| Q4 2022 | 98 | $44.4M |
| Q3 2022 | 94 | $64.7M |
| Q2 2022 | 102 | $66.0M |
| Q1 2022 | 129 | $173.2M |
| Q4 2021 | 139 | $202.2M |
| Q3 2021 | 142 | $417.7M |
| Q2 2021 | 152 | $478.4M |
| Q1 2021 | 152 | $618.6M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Omeros Corp; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CI Private Wealth, LLC | 786,451 | $3.12M | 0.00% | +60,000+8.3% | Added |
| State Street Corp | 1,226,053 | $4.87M | 0.00% | +3,839+0.3% | Added |
| Geode Capital Management, LLC | 1,339,251 | $5.32M | 0.00% | +6,839+0.5% | Added |
| D. E. Shaw & Co., Inc. | 1,605,240 | $6.37M | 0.01% | +28,857+1.8% | Added |
| Stifel Financial Corp | 1,904,207 | $7.56M | 0.01% | +1,613+0.1% | Added |
| Vanguard Group Inc | 3,259,599 | $12.9M | 0.00% | +40,481+1.3% | Added |
| BlackRock, Inc. | 4,229,372 | $16.8M | 0.00% | +4,229,372 | New |
| Ingalls & Snyder LLC | 4,539,415 | $18.0M | 0.71% | −53,733−1.2% | Reduced |
| First Trust Advisors LP | 0 | $0 | 0.00% | −162,803−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −21,482−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −16,295−100.0% | Sold out |
| Empire Life Investments Inc. | 0 | $0 | 0.00% | −8,959−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −3,550−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −511−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −206−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |
| Private Ocean, LLC | – | – | – | – | Not filed |
| Spotlight Asset Group, Inc. | – | – | – | – | Not filed |